EDCTP Alumni Network

Fostering excellence and collaboration in the next generation of researchers

Call Senior Fellowship (SF)
Programme EDCTP1
Start Date 2010-05-14
End Date 2012-05-14
Project Code TA.2009.40200.005
Status Completed

Title

Evolution of neutralizing antibodies among acute to early HIV Subtype C infected individuals in Botswana: one year longitudinal study.

Objectives

To characterise the evolution of neutralising antibodies against HIV-1 subtype C gp 120 molecular envelope clones from acute/and early heterosexual acquired HIV-1 subtype C infections in Botswana

Host Organisation

Institution Country
University of Zimbabwe Zimbabwe
BHP Botswana

Participants

Name Institution Country
Rosemary Musonda Botswana Harvard Partnership (BHP) Botswana
Max Essex Harvard United States
Joseph Makhema Botswana Harvard Partnership (BHP) Botswana

Study Design

Prospective cohort study on the evolution of neutrolising antibodies in HIV –C

Sites

Botswana

Phd Study

Title University Start Date End Date
Evolution of HIV-1C neutralizing antibodies in individuals during acute and early infection in Botswana University of Botswana 2011-03-01 2014-10-11

Students Supervised

Type Name Title University Start Date End Date
PhD Kaebetswe Bedi Dr University of Botswana 2011 2014
MSc Sheron Dzoro Miss University of Botswana 2011 2012

Results & Outcomes

Using stored samples collected from 72 HIV-infected patients in 2005- 2008, 50 plasma samples were analysed. Results so far show that broadly neutralizing antibodies are indeed present during pregnancy and at selected time points during the course of infection in the case of acute and recently infected individuals. Most plasmas have 50% neutralizing capacity, but the majority fail to exhibit 90% neutralisation. There was no strong inhibition of IN93, an HIV-1C strain similar to the predominant subtype C in the region. There is potential of identifying samples that show broad inhibition of various virus strains; with some samples showing high inhibition of subtype B (BR92).

Current Organisation

University of Zimbabwe

Current Job Title

Professor

Awards

12 1. Tackling infections to Benefit Africa (TIBA)
2018 ii. Understanding Schistosomiasis among Children under-Five years

Students Supervised

Type Name Title University Start Date End Date
PhD 4. Sekesai Mtapuri-Zinyowera Prevalence of intestinal protozoan parasites in diverse communities and drinking water bodies in Zimbabwe and water disinfection methods against Giardia duodenalis and Entamoeba histolytica/dispar University of Zimbabwe 2009 2013
DPhil Nicholas Midzi Analysis on the burden of helminths-plasmodium polyparasitism, impact on anaemia and effects of integrated school based parasite control and health education in Zimbabwe University of Zimbabwe 2006 2013
PhD 2. Mable Mwale-Mitengo Immunological and Genetic Profiles in Schistosoma mansoni -Infected Zambian Individuals in Relation to Disease Pathogenesis and Progression University of Zambia 2012 2016
DPhil Tsungai Reid Isolation and characterization of extracts from wild edible and non-edible mushrooms in Zimbabwe University of ZImbabwe 2015 2019
PhD Agness F. Nhidza Immunological effects of asymptomatic enteric pathogens and microbiota in pregnancy and the neonates University of KwaZulu Natal 2014 2017
PhD Tawanda Chisango Investigating Schistosomiasis Markers of Inflammation and Immune Responses in Individuals on Repeated Mass Drug Administration University of KwaZulu Natal 2015 2018
PhD Edison Sibanda Fungal endophytes: isolation, identification and assessment of the bioactive potential of their natural products University of KwaZulu Natal 2015 2018
DPhil Elizabeth Gori Effect of cytokine gene polymorphism on HIV and cardiovascular diseases University of Zimbabwe 2015 2018
DPhil Daniel Chirundu Investigation on Cellphone Reminders to Improve Treatment Adherence among HIV ART Patients - a randomized controlled trial Texila American University 2014 2017

Memberships

Role Committee/board Start Date End Date

Education

Institution Degree Year
University of Glasgow, United Kingdom PhD 1998-02-21
University of Zimbabwe, Zimbabwe MPhilSc 1994
University of Zimbabwe, Zimbabwe B.App.Sc 1992

Areas Of Specialisation

Human Immuno-deficiency Virus (HIV) Neglected Infectious Diseases (NID)

Grants

Grant Code:
12440
Source of funding:
Thrasher Research Fund
Amount:
370000
Role:
Principal Investigator
Start Date:
2015-01-01
End Date:
2020-01-01
Grant Code:
KF2/100075
Source of funding:
The British Academy
Amount:
50000
Role:
Principal Investigator
Start Date:
2018-01-01
End Date:
2020-01-01
Grant Code:
Source of funding:
End Fund, WHO TDR, UNICEF
Amount:
1500000
Role:
Principal Investigator
Start Date:
2012-01-01
End Date:
2020-01-01
Grant Code:
Source of funding:
WHO-TDR
Amount:
100000
Role:
Principal Investigator
Start Date:
2008-01-01
End Date:
2012-01-01
Grant Code:
Source of funding:
End Fund, SCI, UNICEF, WHO TDR
Amount:
224000
Role:
Principal Investigator
Start Date:
2012-01-01
End Date:
2019-01-01
Grant Code:
WT082028MA
Source of funding:
Wellcome Trust
Amount:
357562
Role:
Principal Investigator
Start Date:
2008-01-01
End Date:
2014-01-01
Grant Code:
KF2/100075
Source of funding:
The British Academy
Amount:
50000
Role:
Principal Investigator
Start Date:
2017-01-01
End Date:
2020-01-01
Grant Code:
16/136/33
Source of funding:
NIHR - EoD
Amount:
165000
Role:
Principal Investigator
Start Date:
2018-01-01
End Date:
2020-01-01
Grant Code:
108061/Z/15/Z
Source of funding:
Wellcome Trust
Amount:
99000
Role:
Principal Investigator
Start Date:
2015-01-01
End Date:
2019-01-01

Publications

Authors:
Mduluza T
Chimponda NT
Mduluza-Jokonya LT
Choto ET
Mutapi F
Date:
2018-10-12
Journal:
Current Clinical Microbiology Report
Content:

Urogenital schistosomiasis, caused by the helminth parasite Schistosoma haematobium, is one of the most important childhood public health problems in Africa, compromising child growth and development and usually causing irreversible damage in life leading to increased susceptibility to HIV coinfection in adulthood. Naturally acquired immunity develops slowly, and with no vaccine available, infection and morbidity are controlled by treatment with the antihelminthic drug praziquantel. Treatment is believed to accelerate development of protective immunity. Recent FindingsIn our recent research, we demonstrated that morbidity occurs in young children and that the markers of morbidity can be used for diagnosis, while development of pathology is reduced by a single antihelminthic treatment. Many gaps exist in the control efforts of schistosomiasis that could be initiated during early years of growth to avoid childhood schistosomiasis with immense benefits in adulthood susceptibility or increased HIV transmission. SummaryTreating urogenital schistosomiasis infection during earlier childhood age is a relatively cheap strategy to benefit child health and provide opportunity to develop protective immune responses. Studies on the association of urogenital schistosomiasis with HIV transmission indicate that prevention and protective immunity could be achieved by administering treatment earlier during childhood.

Authors:
Edson Sibanda, Musa Vuyisile Mabandla, Edson Panganayi Sibanda, Musa Mabandla, Tawanda Chisango, Agness Farai Nhidza, Takara Mduluza , Sibanda EP, Mabandla M, Chisango T, Nhidza AF, Mduluza T. Endophytic fungi from Vitex payos: identication and bioactivity. Acta Mycol. 2018;53(2):1111. https://doi. org/10.5586/am.1111 Digital signature This PDF has been certied using digital signature with a trusted timestamp to assure its origin and integrity. A verication trust dialog appears on the PDF document when it is opened in a compatible PDF reader. Certicate properties provide further details such as certication time and a signing reason in case any alterations made to the nal content. If the certicate is missing or invalid it is recommended to verify the article on the journal website. Piotr Otręba Digitally signed by Piotr Otręba Date: 2018.12.06 17:03:54 Z (PDF) Endophytic fungi from Vitex payos: identifcation and bioactivity.. Available from: https://www.researchgate.net/publication/329453205_Endophytic_fungi_from_Vitex_payos_identifcation_and_bioactivity [accessed Dec 13 2018].
Date:
2018-12-13
Journal:
Acta Mycologica
Content:

Endophytic fungi isolated from medicinal plants have an important role to play in the search for new bioactive natural compounds. However, despite their potential as repositories of bioactive compounds, the endophytes of African medicinal plants are largely underexplored. The aim of this study was to isolate and identify the endophytic fungi associated with Vitex payos and evaluate their antimicrobial and antioxidant potential. The surface sterilization technique was used to isolate the endophytic fungi that were identified by rDNA sequencing of the ITS region. Crude methanol and ethyl acetate extracts were screened for antimicrobial activity using the agar diffusion method and evaluated for antioxidant activity using a commercial total antioxidant capacity assay kit. The total phenolic content of the extracts was determined using the Folin-Ciocalteu method and functional groups present in the extracts were predicted using Fourier-transform infrared spectros-copy. Seven endophytic fungi isolates identified as Glomerella acutata, Epicoccum nigrum, Diaporthe species, Penicillium chloroleucon, Diaporthe endophytica, Mucor circinelloides, and Epicoccum nigrum were isolated from the tissues of Vitex payos. None of the extracts exhibited antimicrobial activity and the crude ethyl acetate extract obtained from E. nigrum demonstrated both the highest total phenolic content (2.97 ±0.13 mg GAE g −1 dry weight) and total antioxidant capacity (231.23 ±2.03 μM CRE). Fourier-transform infrared spectral analysis of the crude extracts from E. nigrum confirmed the presence of molecules carrying bonded hydroxyl functional group characteristic of phenolic compounds. These preliminary results indicate that most of the isolated fungal endophytes from V. payos belong to the phylum Ascomycota and that the isolated E. nigrum strain has potential as a source of natural antioxidants.
(PDF) Endophytic fungi from Vitex payos: identifcation and bioactivity.. Available from: https://www.researchgate.net/publication/329453205_Endophytic_fungi_from_Vitex_payos_identifcation_and_bioactivity [accessed Dec 13 2018].

Authors:
Reid Tsungai
Chenjerayi Kashangura
C. Chidewe
M. A. Benhura
B. Stray- Pedersen
Takafira Mduluza
Date:
2018-09-12
Journal:
Medicinal Mushrooms
Content:

Antibiotic resistance has become a global concern and is threatening the clinical efficacy of many existing drugs. This has led to an increased screening of several medicinal sources of potential antimicrobial substances. Mushrooms have long been recognized as valuable source of nutritive and pharmacologically active compounds. The objectives of this study were to isolate and characterize antimicrobial compounds from selected mushroom extracts. Twelve crude extracts of mushrooms using acetone, methanol, ethanol and cold water, namely; Amanita spp, Amanita zambiana, Cantharellus heinemannianus, Cantharellus miomboensis, Cantharellus symoensii, Ganoderma lucidum and Lactarius kabansus, were separated by Preparative Liquid Chromatography (PLC). The separated bands were each scrapped off the silica plates and extracted with 15 ml ethyl acetate, filtered through Whatman no 1 paper and dried under a stream of air. The dried extracts were re-suspended in 1-10 mg/ml methanol or dimethyl sulfoxide. A total of ninety nine compounds were obtained and labelled as compounds 1 to 99. The isolated compounds were screened for their antimicrobial activity against Salmonella typhi using the tetrazolium salt (MTT) cell viability assay. Fourteen of the isolated compounds exhibited high growth inhibition of S. typhi ranging from 62-84.3%. The acetone extract of C. symoensii had the compound with the highest inhibitory activity of 84.3%, at a concentration of 480 µg/ml, followed by C. symoensii from ethanol and methanol extracts, C. miomboensis from ethanol extract and C. symoensii from ethanol extract, showing inhibitory activities of 82.8%, 82.4%, 76.8% and 76.8%, at concentrations of 800 µg/ml, 640 µg/ml, 800 µg/ml and 640 µg/ml, respectively. The tested compounds were identified using standard staining procedures with Dragendorff's reagent for the detection of alkaloids, vanillin-sulphuric acid for terpenoid and phenol derivatives, anisaldehyde-sulphuric acid for flavonoid derivatives, anisidine phthalate for carbohydrates and reducing sugars, diphenylamine for glycosides and glycolipids, ninhydrin for amines and amino sugars, phosphoric acid for sterols and steroids, and iodine for universal stain. The majority of the compounds showed a white fluorescence under UV at 254 nm. Two compounds additionally gave a purple colour when viewed under UV at 365 nm. Four compounds from methanol and ethanol extracts of C. miomboensis and acetone extract of C. symoensii, showed purple spots after staining with anisaldehyde-sulphuriric acid, indicating the presence of flavonoid derivatives. Two of the compounds further gave positive results after staining with vanillin-sulphuric acid on the same spots, confirming the presence of phenol derivatives. The results showed that Cantharellus species possessed antibacterial activity against S. typhi due to the presence of flavonoids. Appropriate extracts of Cantharellus species have potential for developing therapeutic agents against S. typhi.

Projects

Fellow:
Takafira Mduluza
Collaborators:
Name Country Institution
Takafira Mduluza Zimbabwe University of Zimbabwe
Francisca Mutapi` United Kingdom University of Edinburgh
Objectives:
To understand infection trends and development of immunity during early childhood schistosomiasis
Sites:
Zimbabwe
Edinburgh
Study Design:
Longitudinal study-
Subjects:
Under five children
Start Date:
2012-02-01
End Date:
2019-02-28

Send a Message